Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132667) titled 'A Prospective, Multicenter, Single-Arm Clinical Study of Telitacicept Monotherapy for IgA Nephropathy and IgA Vasculitis-Associated Nephritis' on Sept. 17.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: The FIrst Affiliated Hospital, College of Medicine, Zhejiang University

Condition: Active IgA vasculitis nephritis (IgAVN), also known as Henoch-Schonlein purpura nephritis, is one of the most serious complications of IgA vasculitis (IgAV) (formerly Henoch-Schonlein purpura) and belongs to systemic immune-complex-mediated small-vessel vasculitis. The disease is characterized by th...